STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
149
13F, latest reported quarter
Conversions, 180 days
27
Codes C/M, not in net · $5.5M priced
What the filings say about AMBQ
Insiders, 180 days
-$38.4M net sold
6 sellers · 56% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$24.6M
16 notices
Ambiq Micro insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Ambiq Micro, Inc. insiders sold a net $38.4M of stock across 79 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Oct 2, 2026.
The trade is 0.3% of the 218,946 shares held after it.
3 other insiders sold within 30 days.
149 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer Hanson Scott McLean sold about $29.4K of AMBQ under a 10b5-1 plan on Oct 15, 2026; 3 other insiders sold within 30 days and 149 funds added in the latest 13F quarter.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Oct 2, 2026.
The trade is 0.4% of the 218,046 shares held after it.
3 other insiders sold within 30 days.
149 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer Hanson Scott McLean sold about $45.1K of AMBQ under a 10b5-1 plan on Oct 15, 2026; 3 other insiders sold within 30 days and 149 funds added in the latest 13F quarter.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Oct 2, 2026.
The trade is 1.7% of the 214,346 shares held after it.
3 other insiders sold within 30 days.
149 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer Hanson Scott McLean sold about $189.1K of AMBQ under a 10b5-1 plan on Oct 15, 2026; 3 other insiders sold within 30 days and 149 funds added in the latest 13F quarter.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Oct 2, 2026.
The trade is 0.8% of the 212,546 shares held after it.
3 other insiders sold within 30 days.
149 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer Hanson Scott McLean sold about $93.4K of AMBQ under a 10b5-1 plan on Oct 15, 2026; 3 other insiders sold within 30 days and 149 funds added in the latest 13F quarter.
21 earlier Form 4 trades (code P or S) here by this insider (21 sales), the last on Oct 2, 2026.
The trade is 0.1% of the 448,400 shares held after it.
3 other insiders sold within 30 days.
149 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Esaka Fumihide sold about $24.6K of AMBQ under a 10b5-1 plan on Oct 15, 2026; 3 other insiders sold within 30 days and 149 funds added in the latest 13F quarter.
79 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
AMBQ planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
SEAN CHEN
Filed 2026-10-05
$3.6M
Jeffrey G. Winzeler
Filed 2026-10-02
$377.2K
Scott McLean Hanson
Filed 2026-10-02
$600.2K
Fumihide Esaka
Filed 2026-10-02
$1.1M
Sean Chihhsiang Chen
Filed 2026-10-02
$401.2K
AMBQ mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Templeton Global Smaller Companies Fund
$22.8M position · as of 2026-05-31
2.8%
Buffalo Early Stage Growth Fund
$1.9M position · as of 2026-06-30
2.6%
Pear tree essex environmental opportunities fund
$764.3K position · as of 2026-06-30
2.3%
Small-Cap Growth Portfolio
$7.3M position · as of 2026-06-30
1.2%
Goldman Sachs Small Cap Growth Fund
$5.6M position · as of 2026-05-31
1.2%
Wasatch Micro Cap Fund
$7.1M position · as of 2026-06-30
1.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $38.4M sold by insiders over 180 days, 149 funds added last quarter, $24.6M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$97.9M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM AMBQ
FY Dec 2025
$72.5M
FY Dec 2024
n/a
Jun 2026
$33.9M
Mar 2026
$25.1M
Dec 2025
$20.7M
Sep 2025
$18.2M
Jun 2025
$17.9M
Mar 2025
$15.7M
Dec 2024
$20.3M
Sep 2024
$20.3M
At each fiscal year end
Single quarter
Net margin, TTM
-37.8%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM AMBQ
FY Dec 2025
-50.3%
FY Dec 2024
n/a
Jun 2026
-21.0%
Mar 2026
-40.6%
Dec 2025
-51.5%
Sep 2025
-49.6%
Jun 2025
-47.5%
Mar 2025
-52.7%
Dec 2024
-50.1%
Sep 2024
-46.6%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM AMBQ
FY Dec 2025
n/a
FY Dec 2024
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity AMBQ
FY Dec 2025
n/a
FY Dec 2024
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt AMBQ
FY Dec 2025
n/a
FY Dec 2024
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-75.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity AMBQ
FY Dec 2025
n/a
FY Dec 2024
n/a
Jun 2026
-75.9%
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-14.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets AMBQ
FY Dec 2025
-25.2%
FY Dec 2024
n/a
Jun 2026
-14.1%
Mar 2026
-14.8%
Dec 2025
-25.2%
Sep 2025
-19.3%
Jun 2025
-40.8%
Mar 2025
-37.0%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital AMBQ
FY Dec 2025
n/a
FY Dec 2024
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-17.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed AMBQ
FY Dec 2025
-30.7%
FY Dec 2024
n/a
Jun 2026
-17.5%
Mar 2026
-17.8%
Dec 2025
-30.7%
Sep 2025
-21.9%
Jun 2025
-50.1%
Mar 2025
-43.4%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing AMBQ
FY Dec 2025
n/a
FY Dec 2024
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value AMBQ
FY Dec 2025
n/a
FY Dec 2024
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield AMBQ
FY Dec 2025
n/a
FY Dec 2024
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing AMBQ
FY Dec 2025
n/a
FY Dec 2024
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
AMBQ ranks highest on institutional and government (49th percentile) and risk and compliance (24th), and lowest on insider conviction (14th), among Semiconductors & Electronics peers.
Profitability
23
Inputs
Return on equity-75.9% · 12 pct, sector of 154
Return on assets-14.1% · 30 pct, sector of 171
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-17.5% · 28 pct, sector of 155
Growth
23
Inputs
Revenue growth, YoY-4.7% · 23 pct, sector of 194
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
14
Inputs
Net Form 4 buying (codes P and S), 180d-$23.7M · 28 pct, sector of 146
Insider buyers, 180d0 · 0 pct, sector of 150
Institutional and government
49
Inputs
Funds adding, latest quarter149 · 49 pct, sector of 184
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
24
Inputs
Short interest, % of float+12.3% · 24 pct, sector of 220
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Financial health, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
AMBQ filings, in plain words
Are Ambiq Micro insiders buying or selling AMBQ?
In the 180 days to 2026-10-28, Ambiq Micro insiders were net sellers, a net $38.4M across purchases and sales reported on Form 4, by 6 sellers.
Are there planned insider sales of AMBQ?
Yes. 16 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $24.6M of stock; the latest, by SEAN CHEN, was filed 2026-10-05.
Read the full summary
In the 180 days to 2026-10-28, Ambiq Micro insiders were net sellers of AMBQ, a net $38.4M across purchases and sales reported on Form 4 by 6 sellers. 56% of the 75 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 16 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $24.6M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.